News items for the in vitro diagnostics industry for the week of Feb. 10, 2020.
The tests performed well, with researchers suggested they could be used for diagnosis in the future, rather than just screening.
News items for the in vitro diagnostics industry for the week of Dec. 30, 2019
Developers pointed to some success, but they also noted that more at-home tests need to demonstrate higher levels of performance and affordability.
At Medica, the two firms, whose tests have received WHO prequalification, said their tests were seeing high adoption rates in lower-resource nations.
Total revenue during the third quarter was impacted by lower product sales in Africa, but the firm said it saw growth in the US, Latin America, and Asia Pacific.
The firm's CEO said that the approval enables global funders and national ministries of health to expand access to HIV self-testing, allowing diagnosis and treatment.
A recent study from UCSF suggests Abbott's blood-based i-Stat Alinity device may be able to identify TBI that isn't found by a CT scan.
The firm said it anticipates using the loan proceeds to fund its pursuit of corporate priorities, including broadening its product portfolio and geographic reach.